Zurueck zur Suche

Reporte zur Charge 0039B21A

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

6Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
TX 3 VA 2 KY 1

VAERS 1764075

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 0039B21A

mild
Staat
VA
Alter
40,0
Geschlecht
M
Eingang
06.10.2021
Impfdatum
15.04.2021
Beginn
01.05.2021
Tage bis Beginn
16,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test Body temperature Chills Fatigue Injection site inflammation Injection site swelling Lymphadenopathy Nasopharyngitis Pain in extremity Pyrexia Ultrasound scan Vaccination site reaction

Symptomtext

lymph node swelling; fatigue; cold; Patient reported experiencing "Covid arm" - swelling of the arm approximately one week after; hurts sometimes and is visible; swelling up worsen/swelling and inflammation in left; inflammation in the left arm pit worsen, swelling of the whole left armpit the side of administration; fever of 103 degrees; chills; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), VACCINATION SITE REACTION (Patient reported experiencing "Covid arm" - swelling of the arm approximately one week after), PAIN IN EXTREMITY (hurts sometimes and is visible), INJECTION SITE SWELLING (swelling up worsen/swelling and inflammation in left) and INJECTION SITE INFLAMMATION (inflammation in the left arm pit worsen, swelling of the whole left armpit the side of administration) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 0039B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced NASOPHARYNGITIS (cold), VACCINATION SITE REACTION (Patient reported experiencing "Covid arm" - swelling of the arm approximately one week after), PAIN IN EXTREMITY (hurts sometimes and is visible), INJECTION SITE SWELLING (swelling up worsen/swelling and inflammation in left), INJECTION SITE INFLAMMATION (inflammation in the left arm pit worsen, swelling of the whole left armpit the side of administration), PYREXIA (fever of 103 degrees), CHILLS (chills) and FATIGUE (fatigue). On an unknown date, the patient experienced LYMPHADENOPATHY (lymph node swelling). At the time of the report, NASOPHARYNGITIS (cold), PAIN IN EXTREMITY (hurts sometimes and is visible), PYREXIA (fever of 103 degrees), CHILLS (chills) and FATIGUE (fatigue) had resolved, VACCINATION SITE REACTION (Patient reported experiencing "Covid arm" - swelling of the arm approximately one week after) and LYMPHADENOPATHY (lymph node swelling) outcome was unknown and INJECTION SITE SWELLING (swelling up worsen/swelling and inflammation in left) and INJECTION SITE INFLAMMATION (inflammation in the left arm pit worsen, swelling of the whole left armpit the side of administration) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) normal, The doctor did not see any lymphatic inflammation, abnormal, or anything out of the ordinary.. On an unknown date, Body temperature: 103 (High) fever of 103 degrees. On an unknown date, Ultrasound scan: normal (normal) normal, The doctor did not see any lymphatic inflammation, abnormal, or anything out of the ordinary.. No concomitant medication information provided. It was reported that the person may took unknown NSAID to alleviate the adverse events This case was linked to MOD-2021-331783 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 27-Sep-2021: New events Vaccination site reaction and Lymph adenopathy added.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
Test Name: Blood test; Result Unstructured Data: normal, The doctor did not see any lymphatic inflammation, abnormal, or anything out of the ordinary.; Test Name: Body temperature; Result Unstructured Data: fever of 103 degrees; Test Name: ultrasound; Result Unstructured Data: normal, The doctor did not see any lymphatic inflammation, abnormal, or anything out of the ordinary.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1764073

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 0039B21A

mild
Staat
VA
Alter
40,0
Geschlecht
M
Eingang
06.10.2021
Impfdatum
15.04.2021
Beginn
01.04.2021
Tage bis Beginn
-
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Blood test Inappropriate schedule of product administration Injection site inflammation Swelling Ultrasound scan normal

Symptomtext

Inappropriate schedule of product administration; swelling up; inflammation in the left arm pit; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling up), INJECTION SITE INFLAMMATION (inflammation in the left arm pit) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0039B21A and 022C21A) for COVID-19 vaccination. No Medical History information was reported. On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In April 2021, the patient experienced SWELLING (swelling up) and INJECTION SITE INFLAMMATION (inflammation in the left arm pit). On 23-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration). On 23-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of product administration) had resolved. At the time of the report, SWELLING (swelling up) and INJECTION SITE INFLAMMATION (inflammation in the left arm pit) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) The doctor did not see any lymphatic inflammation, abnormal, or anything out of the ordinary. On an unknown date, Ultrasound scan normal: normal (normal) The doctor did not see any lymphatic inflammation, abnormal, or anything out of the ordinary. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. No concomitant medications were provided. No treatment medications were provided This case was linked to MOD-2021-331802 (Patient Link).; Sender's Comments: This case concerns a 40-year-old, male patient with no relevant medical history, who experienced the non-serious event of Swelling and expected non-serious event of Injection site inflammation. The events occurred after the first dose of mRNA-1273 (COVID-19 Vaccine Moderna). An additional event of Inappropriate schedule of product administration is added as dose 1 and dose 2 were administered at a time interval of 38 days. The rechallenge was not applicable. The benefit-risk relationship of mRNA-1273 (COVID-19 Vaccine Moderna) is not affected by this report.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site inflammation
Hospital-Tage
-
Labordaten
Test Name: Blood test; Result Unstructured Data: The doctor did not see any lymphatic inflammation, abnormal, or anything out of the ordinary; Test Name: ultrasound; Result Unstructured Data: The doctor did not see any lymphatic inflammation, abnormal, or anything out of the ordinary
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1790542

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 0039B21A

gering
Staat
KY
Alter
18,0
Geschlecht
M
Eingang
16.10.2021
Impfdatum
07.10.2021
Beginn
07.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

administration of expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration of expired vaccine) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0039B21A) for COVID-19 vaccination. No Medical History information was reported. On 07-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration of expired vaccine). On 07-Oct-2021, EXPIRED PRODUCT ADMINISTERED (administration of expired vaccine) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Reporter reported that date the vial was initially stored in the refrigerator: 02-Sep-2021. Number of doses/vials 10-dose vial No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-345460, MOD-2021-345910, MOD-2021-345833, MOD-2021-345457, MOD-2021-345456, MOD-2021-345931, MOD-2021-345620, MOD-2021-345565, MOD-2021-345619, MOD-2021-345642, MOD-2021-345666 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 08-Oct-2021: Significant follow-up appended _ Reported added & Batch No. updated

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1420489

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 0039B21A

gering
Staat
TX
Alter
68,0
Geschlecht
F
Eingang
23.06.2021
Impfdatum
21.06.2021
Beginn
22.06.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Vaccine Vial was opened on 6/18/2021 and was not discarded at end of day. Same vial was used on Monday 6/21/2021. to vaccinate pt with.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
Hyperlipidemia
Andere Medikamente
unknown
Allergien
Sulfa
Vorherige Impfungen
-

VAERS 1420485

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 0039B21A

gering
Staat
TX
Alter
26,0
Geschlecht
F
Eingang
23.06.2021
Impfdatum
21.06.2021
Beginn
22.06.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Vaccine Vial was opened on 6/18/2021 and was not discarded at end of day. Same vial was used on Monday 6/21/2021. to vaccinate pt with.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1420474

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 0039B21A

gering
Staat
TX
Alter
46,0
Geschlecht
F
Eingang
23.06.2021
Impfdatum
21.06.2021
Beginn
22.06.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

Vaccine Vial was opened on 6/18/2021 and was not discarded at end of day. Same vial was used on Monday 6/21/2021. to vaccinate patient with.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None
Vorgeschichte
Type 2 Diabetes Hyperlipidemia
Andere Medikamente
Unkwown
Allergien
NKDA
Vorherige Impfungen
-